Back
Braze, Inc. Vs. Nektar Therapeutics Industry Stock Comparison
Sell
50
BRZE
Braze, Inc.
Last Price:
$35.32
Seasonality Move:
-12.95%
Sell
42
NKTR
Nektar Therapeutics
Last Price:
$44.85
Seasonality Move:
11.58%
Sell
50
Braze, Inc. (BRZE)
is a Sell
Is Braze, Inc. a Buy, Sell or Hold?
-
The current Braze, Inc. [BRZE] share price is $33.94. The Score for BRZE is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
BRZE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $49.16. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BRZE Stock Price Chart
What is Braze, Inc.'s stock price today?
-
The Braze, Inc. share price today is $33.94Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BRZE is experiencing buying pressure, which is a positive indicator for future bullish movement.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $49.16Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.
BRZE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.54 | Buy |
| Relative Strength Index (14 RSI): | 65.5 | Buy |
| Chaikin Money Flow: | 1912142 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.16 - 32.24) | Buy |
| Bollinger Bands (100): | (26.12 - 30.9) | Buy |
NKTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.43 | Sell |
| Relative Strength Index (14 RSI): | 38.92 | Sell |
| Chaikin Money Flow: | 341847 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
BRZE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.79 | Buy |
| 20-day SMA: | 30.04 | Buy |
| 50-day SMA: | 28.59 | Buy |
| 200-day SMA: | 30.17 | Buy |
| 8-day EMA: | 32.76 | Buy |
| 20-day EMA: | 30.95 | Buy |
| 50-day EMA: | 29.54 | Buy |
| 200-day EMA: | 30.91 | Buy |
NKTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.87 | Sell |
| 20-day SMA: | 57.43 | Sell |
| 50-day SMA: | 58.05 | Sell |
| 200-day SMA: | 31.04 | Buy |
| 8-day EMA: | 54.11 | Sell |
| 20-day EMA: | 56.28 | Sell |
| 50-day EMA: | 55.42 | Sell |
| 200-day EMA: | 38.13 | Buy |
Braze, Inc. Earnings Growth & BRZE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.06 per share, an increase this year of $0.37 per share, and an increase next year of $0.31 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.
Braze, Inc. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nektar Therapeutics Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||